MedTrace Logo

Effects of tDCS on People With Fibromyalgia

NCT05266989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2022-11-14

No results posted yet for this study

Summary

People with fibromyalgia could experience physical and cognitive impairment as well as higher dual-task cost than healthy people when two tasks are performed simultaneously. Transcranial direct current stimulation is a promising non-pharmacological therapy. However, there is insufficient evidence about the intensities dose-response. Therefore, this protocol aims to 1) to compare the effectiveness and the impact of two tDCS intensities (1mA and 2mA) on cognitive, motor, brain functions, and cardiac autonomic modulation; 2) to study the impact of tDCS on the dual-task performance and creativity after applying tDCS in the dorsolateral prefrontal cortex. As hypotheses, a reduction of cognitive-motor interference in dual-task performance and also a modification in neurophysiological parameters, and an improvement in cardiac autonomic modulation are expected. Finally, no different effects are obtained depending on the intensity applied.

Conditions

  • Fibromyalgia

Interventions

OTHER

Transcranial Direct Current Stimulation

Non-invasive technique that modulates the excitability of the cortex by applying low-intensity current

Sponsors & Collaborators

  • Ministerio de Asuntos Economicos y Transformación Digital, España

    collaborator UNKNOWN

  • Junta de Extremadura, España

    collaborator UNKNOWN

  • University of Extremadura

    lead OTHER

Principal Investigators

  • Narcis Gusi · Universidad de Extremadura

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2022-03-14
Completion
2022-03-14

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05266989 on ClinicalTrials.gov